Stock Quote
Renovo Group Plc (RNVO.L) (London Stock Exchange)
26.00p
4:15am EST
+2.97%
25.25p
25.50p
86,326
26.00p
25.50p
35.00p
17.50p
-0.09
335,599
RNVO.L
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Pannone, Rodger | Non-Executive Chairman of the Board | 60,000 |
| Ferguson, Mark | Chief Executive Officer, Executive Director | 582,599 |
| Blain, David | Chief Financial Officer, Company Secretary, Director | -- |
Profile
Renovo Group plc (Renovo) is a United Kingdom-based biopharmaceutical product company engaged in the development of a portfolio of drugs, which exploit different mechanisms of action to reduce scarring at multiple body sites. The Company has three drugs in clinical development. Juvista in Phase III... Full Description
Company Address
Renovo Group Plc
Manchester Incubator Building
48 Grafton Street
Manchester M13 9XX
P: +44161.6067222
F: +44161.6067333
Manchester Incubator Building
48 Grafton Street
Manchester M13 9XX
P: +44161.6067222
F: +44161.6067333
Analyst Research
| RNVO.L | Industry | |
|---|---|---|
| P/E(TTM) | -- | 6.90 |
| P/S(TTM) | 6.11 | 1.54 |
| ROI(TTM) | -18.74 | 6.18 |
| ROE(TTM) | -26.48 | 9.32 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | -8.23 |
| Total Revenue | $4.12M |
| Net Income | $-6.97M |
| EPS | $-0.04 |
